BIOMAT Database Logo BIOMAT Database Logo

DNA repair and synthetic lethality. 2011

Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
School of Public Health, Shandong University, Jinan 250012, China.

Tumors often have DNA repair defects, suggesting additional inhibition of other DNA repair pathways in tumors may lead to synthetic lethality. Accumulating data demonstrate that DNA repair-defective tumors, in particular homologous recombination (HR), are highly sensitive to DNA-damaging agents. Thus, HR-defective tumors exhibit potential vulnerability to the synthetic lethality approach, which may lead to new therapeutic strategies. It is well known that poly (adenosine diphosphate (ADP)-ribose) polymerase (PARP) inhibitors show the synthetically lethal effect in tumors defective in BRCA1 or BRCA2 genes encoded proteins that are required for efficient HR. In this review, we summarize the strategies of targeting DNA repair pathways and other DNA metabolic functions to cause synthetic lethality in HR-defective tumor cells.

UI MeSH Term Description Entries
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D005804 Genes, Lethal Genes whose loss of function or gain of function MUTATION leads to the death of the carrier prior to maturity. They may be essential genes (GENES, ESSENTIAL) required for viability, or genes which cause a block of function of an essential gene at a time when the essential gene function is required for viability. Alleles, Lethal,Allele, Lethal,Gene, Lethal,Lethal Allele,Lethal Alleles,Lethal Gene,Lethal Genes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067856 Poly(ADP-ribose) Polymerase Inhibitors Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. Inhibitors of Poly(ADP-ribose) Polymerase,PARP Inhibitor,Poly(ADP-Ribose) Polymerase Inhibitor,Poly(ADP-ribosylation) Inhibitor,Inhibitors of Poly(ADP-ribose) Polymerases,PARP Inhibitors,Poly(ADP-ribosylation) Inhibitors,Inhibitor, PARP,Inhibitors, PARP
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D016147 Genes, Tumor Suppressor Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible. Antioncogenes,Cancer Suppressor Genes,Emerogenes,Genes, Cancer Suppressor,Genes, Growth Suppressor,Genes, Metastasis Suppressor,Growth Suppressor Genes,Metastasis Suppressor Genes,Tumor Suppressor Genes,Anti-Oncogenes,Genes, Onco-Suppressor,Oncogenes, Recessive,Tumor Suppressing Genes,Anti Oncogenes,Anti-Oncogene,Antioncogene,Cancer Suppressor Gene,Emerogene,Gene, Cancer Suppressor,Gene, Growth Suppressor,Gene, Metastasis Suppressor,Gene, Onco-Suppressor,Gene, Tumor Suppressing,Gene, Tumor Suppressor,Genes, Onco Suppressor,Genes, Tumor Suppressing,Growth Suppressor Gene,Metastasis Suppressor Gene,Onco-Suppressor Gene,Onco-Suppressor Genes,Oncogene, Recessive,Recessive Oncogene,Recessive Oncogenes,Suppressor Gene, Cancer,Suppressor Gene, Growth,Suppressor Gene, Metastasis,Suppressor Genes, Cancer,Suppressor Genes, Growth,Suppressor Genes, Metastasis,Tumor Suppressing Gene,Tumor Suppressor Gene

Related Publications

Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
DNA Double Strand Break Repair - Related Synthetic Lethality.
January 2019, Current medicinal chemistry,
Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
Evolving DNA repair synthetic lethality targets in cancer.
December 2022, Bioscience reports,
Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality.
November 2016, Trends in cancer,
Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
DNA Damage Repair Deficiency and Synthetic Lethality for Cancer Treatment.
January 2021, Trends in molecular medicine,
Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
Synthetic lethality: exploiting the addiction of cancer to DNA repair.
June 2011, Blood,
Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
Targeting cancer-specific synthetic lethality in double-strand DNA break repair.
June 2009, Cell cycle (Georgetown, Tex.),
Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.
June 2021, Cancer research,
Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
Targeting synthetic lethality in DNA damage repair pathways as an anti-cancer strategy.
October 2010, Current drug targets,
Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
Synthetic lethality between murine DNA repair factors XLF and DNA-PKcs is rescued by inactivation of Ku70.
September 2017, DNA repair,
Gong-She Guo, and Feng-Mei Zhang, and Rui-Jie Gao, and Robert Delsite, and Zhi-Hui Feng, and Simon N Powell
"Contextual" synthetic lethality and/or loss of heterozygosity: tumor hypoxia and modification of DNA repair.
September 2010, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!